Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Skin Diseases × Cetuximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 116 Head and Neck Neoplasms 81 Squamous Cell Carcinoma of Head and Neck 77 Carcinoma, Non-Small-Cell Lung 50 Colonic Neoplasms 37 Rectal Neoplasms 33 Neoplasm Metastasis 28 Neoplasms 25 Pancreatic Neoplasms 20 Lung Neoplasms 16 Carcinoma, Squamous Cell 15 Stomach Neoplasms 14 Esophageal Neoplasms 13 Tongue Neoplasms 10 Recurrence 9 Laryngeal Neoplasms 9 Breast Neoplasms 9 Salivary Gland Neoplasms 8 Mouth Neoplasms 8 Esophageal Squamous Cell Carcinoma 8 Adenocarcinoma Of Esophagus 8 Adenocarcinoma of Lung 7 Neoplasms, Squamous Cell 6 Hypopharyngeal Neoplasms 6 Carcinoma 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Oropharyngeal Neoplasms 5 Nasopharyngeal Carcinoma 5 Carcinoma, Renal Cell 5 Precancerous Conditions 4

Interventions

binimetinib 2 ipatasertib 1 exemestane 1 encorafenib 1 baricitinib 1 atezolizumab 1 Vemurafenib 1 VP-102 1 Spironolactone 1 Paclitaxel 1 Low-Level Light Therapy 1 Leuprolide 1 Everolimus 1 Equipment and Supplies 1 Dacarbazine 1 Cetuximab 1 Cantharidin 1 BF-200 ALA 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00240682 2012-02-22

CTXSCC

Centre Hospitalier of Chartres

Phase 2 Completed

Carcinoma, Squamous Cell, Skin Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡